{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:25:30Z","timestamp":1771561530448,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clineuro.2026.109336","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:01:36Z","timestamp":1769616096000},"page":"109336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anti-LGI-1 autoimmune encephalitis: Insights from literature and a very late-onset case report"],"prefix":"10.1016","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5790-8488","authenticated-orcid":false,"given":"Cansu","family":"Sar\u0131kaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beng\u00fcl Fatma","family":"G\u00f6lge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan Aykut","family":"Bing\u00f6l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berrin","family":"Aktekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Karabudak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clineuro.2026.109336_bib1","first-page":"995","article-title":"Autoimmune encephalitis","volume":"30","author":"Irani","year":"2024","journal-title":"Contin. (Minne Minn. )"},{"issue":"5","key":"10.1016\/j.clineuro.2026.109336_bib2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"van Sonderen","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2026.109336_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1474-4422(23)00083-2","article-title":"Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease","volume":"22","author":"Dalmau","year":"2023","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.clineuro.2026.109336_bib4","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1080\/00207454.2018.1512985","article-title":"Three cases of antibody-LGI1 limbic encephalitis and review of literature","volume":"129","author":"Bing-Lei","year":"2019","journal-title":"Int J. Neurosci."},{"key":"10.1016\/j.clineuro.2026.109336_bib5","article-title":"Clinical features and therapeutic effects of anti-leucine-rich glioma inactivated 1 encephalitis: a systematic review","volume":"12","author":"Teng","year":"2021","journal-title":"Front Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109336_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s42494-023-00132-5","article-title":"Heterogeneity of clinical features, EEG and brain imaging findings in anti-leucine-rich glioma-inactivated protein 1 autoimmune encephalitis: a retrospective case series study and review of the literature","volume":"5","author":"Huang","year":"2023","journal-title":"Acta Epileptol."},{"key":"10.1016\/j.clineuro.2026.109336_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinph.2025.2110753","article-title":"Seizure and electroencephalographic characteristics in anti-LGI1 encephalitis","volume":"175","author":"Shen","year":"2025","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.clineuro.2026.109336_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108571","article-title":"Electroclinical biomarkers of autoimmune encephalitis","volume":"128","author":"Wesselingh","year":"2022","journal-title":"Epilepsy Behav."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109336_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70107","article-title":"Microglial activation visualized by [18F]-DPA714 PET is a potential marker of severity and prognosis for anti-LGI1 encephalitis","volume":"32","author":"Wang","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2026.109336_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1623577","article-title":"Subcortical shape biomarkers reveal limbic and basal ganglia damage in anti-LGI1 encephalitis","volume":"16","author":"Qiao","year":"2025","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.clineuro.2026.109336_bib11","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001136","article-title":"Cortical and subcortical dysmetabolism are dynamic markers of clinical disability and course in anti-LGI1 encephalitis","volume":"9","author":"Rissanen","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109336_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41420-025-02459-z","article-title":"Immunotherapy for autoimmune encephalitis","volume":"11","author":"Cheng","year":"2025","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109336_bib13","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200178","article-title":"Clinical determinants of longitudinal disability in LGI-1-IgG autoimmune encephalitis","volume":"11","author":"Aboseif","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.clineuro.2026.109336_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1281276","article-title":"Comparing clinical features, severity and prognosis of autoimmune encephalitis with and without oligoclonal bands","volume":"14","author":"Xue","year":"2024","journal-title":"Front Neurol."},{"issue":"9","key":"10.1016\/j.clineuro.2026.109336_bib15","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1007\/s00415-022-11162-3","article-title":"Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies","volume":"269","author":"Guery","year":"2022","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109336_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-025-00650-1","article-title":"Autoimmune encephalitis","volume":"11","author":"de Bruijn","year":"2025","journal-title":"Nat. Rev. Dis. Prim."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T03:35:58Z","timestamp":1771558558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846726000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":16,"alternative-id":["S0303846726000284"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109336","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-LGI-1 autoimmune encephalitis: Insights from literature and a very late-onset case report","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109336"}}